HIV/AIDS deaths averted by antiretroviral therapy, annual growth rate in Syrian Arab Republic

Syrian Arab Republic: HIV/AIDS deaths averted by antiretroviral therapy, annual growth rate was 16.4 % change on previous year in 2024. ◆ Volatile

Latest (2024)
16.4 % change on previous year
Change on year
up 87.2%
World rank
12th
of 157 countries
All-time high
266.31 % change on previous year
in 2004
All-time low
-2.93 % change on previous year
in 2014
Years of data
21
2004–2024

HIV/AIDS deaths averted by antiretroviral therapy, annual growth rate in Syrian Arab Republic, 2004–2024

01002003002004201420242004: 266.3 % change on previous year2005: 41.4 % change on previous year2006: 1.4 % change on previous year2007: 14.3 % change on previous year2008: 12 % change on previous year2009: 20.4 % change on previous year2010: 20.3 % change on previous year2011: 21.9 % change on previous year2012: 18.2 % change on previous year2013: -1.5 % change on previous year2014: -2.9 % change on previous year2015: -1.3 % change on previous year2016: -1 % change on previous year2017: 17.9 % change on previous year2018: 31.3 % change on previous year2019: 24.4 % change on previous year2020: 13.6 % change on previous year2021: 1.8 % change on previous year2022: 1.3 % change on previous year2023: 8.8 % change on previous year2024: 16.4 % change on previous year

Source: Statizoid (derived). Measured in % change on previous year.

Analysis

The most recent figure for hiv/aids deaths averted by antiretroviral therapy, annual growth rate in Syrian Arab Republic is 16.4 % change on previous year, measured in 2024.

The figure is up 87.2% on the previous year and up 659.3% over ten years.

Over the whole period, hiv/aids deaths averted by antiretroviral therapy, annual growth rate in Syrian Arab Republic peaked at 266.31 % change on previous year in 2004 and was at its lowest, -2.93 % change on previous year, in 2014.

That places Syrian Arab Republic 12th out of 157 countries with data for 2024, putting it in the top 10%.

The series is highly variable year to year, so single readings are best treated with caution.

HIV/AIDS deaths averted by antiretroviral therapy, annual growth rate in Syrian Arab Republic, year by year

Annual values for HIV/AIDS deaths averted by antiretroviral therapy, annual growth rate in Syrian Arab Republic, 2004 to 2024.
Year % change on previous year Change
2004 266.31 % change on previous year
2005 41.42 % change on previous year -84.4%
2006 1.41 % change on previous year -96.6%
2007 14.26 % change on previous year +912.5%
2008 11.95 % change on previous year -16.2%
2009 20.38 % change on previous year +70.5%
2010 20.29 % change on previous year -0.4%
2011 21.94 % change on previous year +8.1%
2012 18.18 % change on previous year -17.1%
2013 -1.48 % change on previous year -108.1%
2014 -2.93 % change on previous year +98.0%
2015 -1.26 % change on previous year -57.1%
2016 -1.02 % change on previous year -18.9%
2017 17.89 % change on previous year -1852.1%
2018 31.34 % change on previous year +75.2%
2019 24.35 % change on previous year -22.3%
2020 13.59 % change on previous year -44.2%
2021 1.79 % change on previous year -86.8%
2022 1.33 % change on previous year -25.6%
2023 8.76 % change on previous year +558.0%
2024 16.4 % change on previous year +87.2%

Syrian Arab Republic compared with similar countries

  • Syrian Arab Republic's 16.4 % change on previous year is above the median for low income countries, which is 1.02 % change on previous year, 16.1× the median. (24 countries reporting)
  • Syrian Arab Republic's 16.4 % change on previous year is above the median for Middle East, North Africa, Afghanistan & Pakistan, which is 8.88 % change on previous year, 1.8× the median. (22 countries reporting)

Biggest year-on-year movements

Years where HIV/AIDS deaths averted by antiretroviral therapy, annual growth rate in Syrian Arab Republic changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.

YearChange FromTo
2017 +1852.1% -1.02 % change on previous year 17.89 % change on previous year
2007 +912.5% 1.41 % change on previous year 14.26 % change on previous year

Averages by decade

DecadeAverage LowestHighest Years
2000s 59.29 % change on previous year 1.41 % change on previous year 266.31 % change on previous year 6
2010s 12.73 % change on previous year -2.93 % change on previous year 31.34 % change on previous year 10
2020s 8.37 % change on previous year 1.33 % change on previous year 16.4 % change on previous year 5

Countries ranked near Syrian Arab Republic

  1. 9 Jordan 19.4 % change on previous year compare
  2. 10 Egypt 18.93 % change on previous year compare
  3. 11 Ireland 16.45 % change on previous year compare
  4. 13 Suriname 14.37 % change on previous year compare
  5. 14 Luxembourg 14.2 % change on previous year compare
  6. 15 Bangladesh 13.71 % change on previous year compare

See the full ranking of 157 places →

More health data for Syrian Arab Republic

All data for Syrian Arab Republic →

Frequently asked questions

What is hiv/aids deaths averted by antiretroviral therapy, annual growth rate in Syrian Arab Republic?
Hiv/aids deaths averted by antiretroviral therapy, annual growth rate in Syrian Arab Republic was 16.4 % change on previous year in 2024, according to Statizoid (derived).
What is the highest hiv/aids deaths averted by antiretroviral therapy, annual growth rate recorded in Syrian Arab Republic?
The highest recorded value was 266.31 % change on previous year in 2004.
What is the lowest hiv/aids deaths averted by antiretroviral therapy, annual growth rate recorded in Syrian Arab Republic?
The lowest recorded value was -2.93 % change on previous year in 2014.
How does Syrian Arab Republic rank for hiv/aids deaths averted by antiretroviral therapy, annual growth rate?
Syrian Arab Republic ranks 12th out of 157 countries with data for 2024.
Is hiv/aids deaths averted by antiretroviral therapy, annual growth rate rising or falling in Syrian Arab Republic?
Over the last ten years it is up 659.3%. The long-run trend across the full record is volatile.
Where does this Syrian Arab Republic data come from?
The figures come from Statizoid (derived), published as part of HIV/AIDS deaths averted by antiretroviral therapy, annual growth rate. Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 21 observations, free to reuse under Derived by Statizoid from the sources named on the page.

Share, cite or embed this page

Cite this page

HIV/AIDS deaths averted by antiretroviral therapy, annual growth rate in Syrian Arab Republic. Statizoid, drawing on Statizoid (derived). Retrieved 14 September 2026, from https://health.statizoid.com/stat/hiv-aids-deaths-averted-by-antiretroviral-therapy-annual-growth-rate/syrian-arab-republic/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under Derived by Statizoid from the sources named on the page; please keep the attribution.

<a href="https://health.statizoid.com/stat/hiv-aids-deaths-averted-by-antiretroviral-therapy-annual-growth-rate/syrian-arab-republic/">HIV/AIDS deaths averted by antiretroviral therapy, annual growth rate in Syrian Arab Republic</a> — Statizoid

How this figure is calculated

The year-on-year percentage change in HIV/AIDS deaths averted by antiretroviral therapy. Computed from consecutive annual observations; years either side of a gap are skipped rather than bridged.

Computed from

Statizoid computes this series; the underlying measurements belong to the publishers named above. The arithmetic is applied to every country and year where both inputs report, and nothing is estimated unless the page says so.

About this data

Indicator
HIV/AIDS deaths averted by antiretroviral therapy, annual growth rate
Unit
% change on previous year
Source
Statizoid (derived)
Licence
Derived by Statizoid from the sources named on the page
Coverage
157 places, 3,585 data points, 1996–2024
Last refreshed

The year-on-year percentage change in HIV/AIDS deaths averted by antiretroviral therapy. Computed from consecutive annual observations; years either side of a gap are skipped rather than bridged.